These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 22627726

  • 1. Role of oral cyclophosphamide in the treatment of giant cell arteritis.
    Quartuccio L, Maset M, De Maglio G, Pontarini E, Fabris M, Mansutti E, Mariuzzi L, Pizzolitto S, Beltrami CA, De Vita S.
    Rheumatology (Oxford); 2012 Sep; 51(9):1677-86. PubMed ID: 22627726
    [Abstract] [Full Text] [Related]

  • 2. Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
    de Boysson H, Boutemy J, Creveuil C, Ollivier Y, Letellier P, Pagnoux C, Bienvenu B.
    Semin Arthritis Rheum; 2013 Aug; 43(1):105-12. PubMed ID: 23453684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I, Henes JC, Wagner AD, Loock J, Gross WL.
    Clin Exp Rheumatol; 2012 Aug; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [Abstract] [Full Text] [Related]

  • 7. Effective treatment administration of cyclophosphamide in membranous nephropathy.
    Dede F, Ayili D, Sahiner S.
    J Nephrol; 2008 Aug; 21(4):560-5. PubMed ID: 18651546
    [Abstract] [Full Text] [Related]

  • 8. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X, Li H, Chen J, He Q, Lv R, Lin W, Li Q, He X, Qu L, Suya W.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [Abstract] [Full Text] [Related]

  • 9. Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centres.
    Loock J, Henes J, Kötter I, Witte T, Lamprecht P, Schirmer M, Gross WL.
    Clin Exp Rheumatol; 2012 Jun; 30(1 Suppl 70):S70-6. PubMed ID: 22640650
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
    Adizie T, Christidis D, Dharmapaliah C, Borg F, Dasgupta B.
    Int J Clin Pract; 2012 Sep; 66(9):906-9. PubMed ID: 22897467
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
    Mahr AD, Jover JA, Spiera RF, Hernández-García C, Fernández-Gutiérrez B, Lavalley MP, Merkel PA.
    Arthritis Rheum; 2007 Aug; 56(8):2789-97. PubMed ID: 17665429
    [Abstract] [Full Text] [Related]

  • 12. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate.
    Ozen S, Duzova A, Bakkaloglu A, Bilginer Y, Cil BE, Demircin M, Davin JC, Bakkaloğlu M.
    J Pediatr; 2007 Jan; 150(1):72-6. PubMed ID: 17188618
    [Abstract] [Full Text] [Related]

  • 13. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE, Woreta FA, Jabs DA, Anhalt GJ.
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [Abstract] [Full Text] [Related]

  • 14. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
    J Nephrol; 2008 Dec; 21(4):584-91. PubMed ID: 18651550
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 16. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
    Koldingsnes W, Nossent JC.
    J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
    [Abstract] [Full Text] [Related]

  • 17. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.
    Alibaz-Öner F, Kelesoglu B, Balci MA, Yardimci GK, Armağan B, Kiliç L, Karakaş Ö, Erden A, Yasar Bilge S, Kardaş RC, Küçük H, Zengin O, Tasci M, Kocaer SB, Yavuz S, Dogru A, Şahin M, Bayindir O, Sevik G, Ertürk Z, Alpay-Kanitez N, Gogebakan H, Tezcan ME, Oksuz MF, Cefle A, Kucuksahin O, Yazici A, Kasapoglu E, Bes C, Unal AU, Dalkiliç E, Yildirim Çetin G, Aksu K, Keser G, Onen F, Çobankara V, Kisacik B, Onat AM, Öztürk MA, Kaşifoğlu T, Omma A, Karadag O, Ates A, Direskeneli H.
    Clin Exp Rheumatol; 2024 Apr; 42(4):816-821. PubMed ID: 37976117
    [Abstract] [Full Text] [Related]

  • 18. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
    de Seze J, Delalande S, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Hatron PY, Vermersch P.
    J Rheumatol; 2006 Apr; 33(4):709-11. PubMed ID: 16583474
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 20. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Détrée F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M.
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.